| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |